Tag: T-knife
Biotech has to adjust to a dry spell in terms of financing
DNA experiment In view of the declining inflow of capital, rapid successes are required in research. (Photo: imago images/Westend61) Frankfurt The collapse of the Silicon Valley Bank (SVB) and the…
The new magic bullet against cancer
Monday 13 June 2022 Log in subscription Newsletter podcast Club e-paper archive Shop jobs Inside my news Home politics Germany Economy International Economic Education company Industry energy Trade + consumer…
German biotech companies: growth in a difficult environment
on the trail of genes Preparing a sample for genetic analysis: German biotech companies are in demand with investors. (Photo: IMAGO/Westend61) Frankfurt At first glance, investments in the German biotech…
Financing boom in the pharmaceutical industry: German biotechs lure
Frankfurt German biotech companies were able to raise around 2.3 billion euros in capital last year. This was the second-highest amount of financing for the industry in its 30-year history.…
Using killer cells to fight cancer: researchers are promoting CAR therapy
Biontech boss Ugur Sahin, Medigene boss Dolores Schendel, patient Emily Whitehead From the point of view of many experts, the novel immunotherapies mark a new era in cancer treatment, Frankfurt…
Using killer cells to fight cancer: researchers are promoting CAR therapy
Biontech boss Ugur Sahin, Medigene boss Dolores Schendel, patient Emily Whitehead From the point of view of many experts, the novel immunotherapies mark a new era in cancer treatment, Frankfurt…
$ 900 million deal with pharmaceutical company BMS
Immatics laboratory in Tübingen The biotech company, founded in 2000, develops novel therapies against cancer. (Photo: Immatics Biotechnologies GmbH) Frankfurt The Tübingen-based biotech company Immatics signs a development and marketing…
With donor cells against cancer
Frankfurt Gerhard Ehninger moved a lot in his life – as a doctor and as a researcher. The medical professor co-founded the German bone marrow donor database, taught for two…
Tomorrow’s biontech: venture capitalists reveal Germany’s biotech hopes
Frankfurt The success of the Covid-19 vaccine developer Biontech has brought new attention to German biotech companies. However, regardless of the success of Biontech, the industry has again moved more…